华森制药实控人游洪涛拟套现2亿 控股股东年内套现2亿

Core Viewpoint - Huason Pharmaceutical (002907.SZ) announced a share reduction plan by its controlling shareholder and an associated fund, which will not affect the company's control or governance structure [1][3]. Share Reduction Plan - Shareholder You Hongtao plans to reduce up to 6,649,826 shares through block trading, accounting for 1.59% of the total share capital, within three months starting from November 6, 2025 [1]. - Shanghai Tiancheng Investment Management Co., Ltd. plans to reduce up to 5,878,000 shares, comprising 1.41% of the total share capital, through both centralized bidding and block trading [1][2]. Financial Implications - The total planned reduction by You Hongtao and Tiancheng Tianli No.1 Fund amounts to 12,527,826 shares, or 3% of the total share capital, with an estimated cash-out of approximately 204.96 million yuan based on the last closing price of 16.36 yuan per share [2][3]. Shareholding Structure - As of the announcement date, You Hongtao holds 72,422,000 shares, while Tiancheng Tianli No.1 Fund holds 5,878,000 shares [3]. - The controlling shareholders, including You Hongtao, have a combined holding of 68% as of June 30, 2025, and the reduction will not lead to a change in control [3]. Previous Share Reductions - From June 6 to July 29, 2025, the controlling shareholder Chengdu Dijiang reduced 12,527,826 shares, representing 3% of the total share capital, with a reduction amounting to approximately 194 million to 216 million yuan [4].